Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) - USD ($) $ in Thousands	Common Stock and Warrant Issuance [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock and Warrant Issuance [Member] Preferred Stock [Member]	Common Stock and Warrant Issuance [Member] Common Stock [Member]	Common Stock and Warrant Issuance [Member] Additional Paid-in Capital [Member]	Common Stock and Warrant Issuance [Member] Retained Earnings [Member]	Common Stock and Warrant Issuance [Member] AOCI Attributable to Parent [Member]	Common Stock and Warrant Issuance [Member]	ATM Offering [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	ATM Offering [Member] Preferred Stock [Member]	ATM Offering [Member] Common Stock [Member]	ATM Offering [Member] Additional Paid-in Capital [Member]	ATM Offering [Member] Retained Earnings [Member]	ATM Offering [Member] AOCI Attributable to Parent [Member]	ATM Offering [Member]	Private Placement [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member]	Private Placement [Member] Common Stock [Member]	Private Placement [Member] Additional Paid-in Capital [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member] AOCI Attributable to Parent [Member]	Private Placement [Member]	Share Subscription Facility Agreement - GEM [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Share Subscription Facility Agreement - GEM [Member] Preferred Stock [Member]	Share Subscription Facility Agreement - GEM [Member] Common Stock [Member]	Share Subscription Facility Agreement - GEM [Member] Additional Paid-in Capital [Member]	Share Subscription Facility Agreement - GEM [Member] Retained Earnings [Member]	Share Subscription Facility Agreement - GEM [Member] AOCI Attributable to Parent [Member]	Share Subscription Facility Agreement - GEM [Member]	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2022																													0	0	6,644,299
Balance at Dec. 31, 2022																													$ 0	$ 0	$ 7	$ 230,399	$ (222,997)	$ 0	$ 7,409
Stock-based compensation																													0	0	0	695	0	0	695
Stock issuances, net (in shares)	0	0	386,667
Stock issuances, net	$ 0	$ 0	$ 0	$ 2,545	$ 0	$ 0	$ 2,545
Net loss																													$ 0	$ 0	$ 0	0	(11,039)	0	(11,039)
Balance (in shares) at Mar. 31, 2023																													0	0	7,030,966
Change in fair value of convertible note attributed to credit risk																													$ 0	$ 0	$ 0	0	0	106	106
Balance at Mar. 31, 2023																													$ 0	$ 0	$ 7	233,639	(234,036)	106	(284)
Balance (in shares) at Dec. 31, 2022																													0	0	6,644,299
Balance at Dec. 31, 2022																													$ 0	$ 0	$ 7	230,399	(222,997)	0	7,409
Net loss																																			(25,818)
Balance (in shares) at Sep. 30, 2023																													3,000,000,000	0	8,391,956,000
Change in fair value of convertible note attributed to credit risk																																			(22)
Balance at Sep. 30, 2023																													$ 3	$ 0	$ 8	242,609	(248,815)	(22)	(6,217)
Balance (in shares) at Mar. 31, 2023																													0	0	7,030,966
Balance at Mar. 31, 2023																													$ 0	$ 0	$ 7	233,639	(234,036)	106	(284)
Stock-based compensation																													$ 0	$ 0	$ 0	544	0	0	544
Stock issuances, net (in shares)	0	0	967,000
Stock issuances, net	$ 0	$ 0	$ 1	5,576	0	0	5,577
Shares issued as repayment of principal and interest for convertible note (in shares)																													0	0	40,867
Shares issued as repayment of principal and interest for convertible note																													$ 0	$ 0	$ 0	200	0	0	200
Net loss																													$ 0	$ 0	$ 0	0	(8,717)	0	(8,717)
Balance (in shares) at Jun. 30, 2023																													0	0	8,038,833
Change in fair value of convertible note attributed to credit risk																													$ 0	$ 0	$ 0	0	0	(128)	(128)
Balance at Jun. 30, 2023																													0	0	8	239,959	(242,753)	(22)	(2,808)
Stock-based compensation																													0	0	0	351	0	0	351
Conversion of Series A preferred stock into common stock																													$ 0	$ 0	$ 0	782	0	0	782
Stock issuances, net (in shares)																						0	0	67,568
Stock issuances, net																						$ 0	$ 0	$ 0	$ 250	$ 0	$ 0	$ 250
Shares issued as repayment of principal and interest for convertible note (in shares)																													0	0	285,555
Net loss																													$ 0	$ 0	$ 0	0	(6,062)	0	(6,062)
Balance (in shares) at Sep. 30, 2023																													3,000,000,000	0	8,391,956,000
Change in fair value of convertible note attributed to credit risk																																			0
Preferred stock and warrants issued, net of issuance costs $27 (in shares)																													3,000,000	0	0
Preferred stock and warrants issued, net of issuance costs $27																													$ 3	$ 0	$ 0	1,168	0	0	1,171
Adjustment for deferred offering cost settlement																													0	0	0	99	0	0	99
Balance at Sep. 30, 2023																													$ 3	$ 0	$ 8	242,609	(248,815)	(22)	(6,217)
Balance (in shares) at Dec. 31, 2023																													3,000,000	0	8,391,940
Balance at Dec. 31, 2023																													$ 3	$ 0	$ 8	241,406	(253,147)	(3)	(11,733)
Stock-based compensation																													$ 0	$ 0	$ 0	242	0	0	242
Conversion of Series A preferred stock into common stock (in shares)																														0	300,000
Conversion of Series A preferred stock into common stock																														$ 0	$ 0	3	0	0	0
Conversion of Series A preferred stock into common stock (in shares)																													(3,000,000)
Conversion of Series A preferred stock into common stock																													$ (3)
Stock issuances, net (in shares)	0	0	575,000					0	0	34,584					0	0	270,000
Stock issuances, net	$ 0	$ 0	$ 1	1,343	0		1,344	$ 0	$ 0	$ 0	$ 179	$ 0	$ 0	$ 179	$ 0	$ 0	$ 0	$ 1,027	$ 0	$ 0	$ 1,027
Warrants issued pursuant to the Alvogen Agreement amendment (see Note 6)																													$ 0	$ 0	$ 0	0	0	0	0
Vesting of restricted stock awards (in shares)																													0	0	57,500
Vesting of restricted stock awards																													$ 0	$ 0	$ 0	0	0	0	0
Shares issued as repayment of principal and interest for convertible note (in shares)																													0	0	143,648
Shares issued as repayment of principal and interest for convertible note																													$ 0	$ 0	$ 1	399	0	0	400
Net loss																													$ 0	$ 0	$ 0	0	(6,528)	0	(6,528)
Balance (in shares) at Mar. 31, 2024																													0	0	9,772,672
Balance at Mar. 31, 2024																													$ 0	$ 0	$ 10	244,599	(259,675)	(3)	(15,069)
Balance (in shares) at Dec. 31, 2023																													3,000,000	0	8,391,940
Balance at Dec. 31, 2023																													$ 3	$ 0	$ 8	241,406	(253,147)	(3)	$ (11,733)
Stock issuances, net (in shares)																																			1,700,000
Net loss																																			$ (16,048)
Balance (in shares) at Sep. 30, 2024																													0	0	11,373,246
Change in fair value of convertible note attributed to credit risk																																			(3)
Balance at Sep. 30, 2024																													$ 0	$ 0	$ 11	250,362	(269,195)	0	(18,822)
Balance (in shares) at Mar. 31, 2024																													0	0	9,772,672
Balance at Mar. 31, 2024																													$ 0	$ 0	$ 10	244,599	(259,675)	(3)	(15,069)
Stock-based compensation																													0	0	0	97	0	0	97
Stock issuances, net (in shares)	0	0	698,050					0	0	247,868
Stock issuances, net	$ 0	$ 0	$ 1	$ 1,913	$ 0	$ 0	$ 1,914	$ 0	$ 0	$ 0	1,228	0	0	1,228
Net loss																													$ 0	$ 0	$ 0	0	(7,897)	0	(7,897)
Issuance of shares related to reverse stock split (in shares)																													0	0	73,040
Contract cost related to Alvogen termination (see Note 6)																													$ 0	$ 0	$ 0	1,336	0	0	1,336
Balance (in shares) at Jun. 30, 2024																													0	0	10,791,630
Balance at Jun. 30, 2024																													$ 0	$ 0	$ 11	249,173	(267,572)	(3)	(18,391)
Stock-based compensation																													$ 0	$ 0	$ 0	104	0	0	104
Stock issuances, net (in shares)								0	0	103,063
Stock issuances, net								$ 0	$ 0	$ 0	$ 219	$ 0	$ 0	$ 219
Shares issued as repayment of principal and interest for convertible note (in shares)																													0	0	458,553
Shares issued as repayment of principal and interest for convertible note																													$ 0	$ 0	$ 0	829	0	0	829
Net loss																													$ 0	$ 0	$ 0	0	(1,623)	0	(1,623)
Balance (in shares) at Sep. 30, 2024																													0	0	11,373,246
Common stock issued in exchange for services (in shares)																													0	0	20,000
Common stock issued in exchange for services																													$ 0	$ 0	$ 0	37	0	0	37
Reclassification of AOCI upon settlement of Streeterville Note																													0	0	0	0	0	3	3
Change in fair value of convertible note attributed to credit risk																																			(3)
Balance at Sep. 30, 2024																													$ 0	$ 0	$ 11	$ 250,362	$ (269,195)	$ 0	$ (18,822)